Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sanofi chief says he could have done a better job outlining R&D plan
Ist Teil von
FT.com, 2023-12-07
Ort / Verlag
London: The Financial Times Limited
Erscheinungsjahr
2023
Link zum Volltext
Beschreibungen/Notizen
Hudson is under pressure to prove that pouring additional billions into drug research internally will solve Sanofi’s innovation woes, as opposed to splashing out on deals to acquire top-level science, after shares dropped almost 20 per cent when the plan was announced in October. Hudson remains bullish, however, arguing that the success rate of mid-stage trials has increased by 50 per cent, bolstering the numbers of candidates in the crucial phase 3 during the four years since he took over as chief executive with a mandate to turn the company around. There are now many generic versions of the drug, which was launched in 2002 and is also used to treat various forms of psoriasis, but Hudson believes there would still be a significant market for a pill that treated the same conditions.